Maulik R. Shah, MD, PhD

Maulik Shah, MD, PhD
 

Medical Director
Genetic Medicine Clinic
Gainesville, Florida
Assistant Clinical Professor
University of Florida School of Medicine
Gainesville, Florida
Assistant Professor of Internal Medicine
University of Central Florida
Orlando, Florida


What are the multiple benefits of carrier screening? Why should carrier testing be a routine part of the prenatal evaluation process? And what ethnic groups or families will benefit most?

What are the multiple benefits of carrier screening? Why should carrier testing be a routine part of the prenatal evaluation process? And what ethnic groups or families will benefit most?

Can you be specific about which families -- based on historical features, ethnicity, and other factors -- should be offered carrier testing? Should it be offered to all families prior to conception?

Can you be more specific about which families -- based on historical features, ethnicity, and other factors -- should be offered carrier testing and when? Should it be offered to all families prior to conception?

What current lab technologies -- including high throughput NGS -- have made expanded carrier screening possible? What do the panels report? How many disorders can be screened?

What current lab technologies -- including high throughput NGS -- have made expanded carrier screening possible? What do the panels report? How many disorders can be screened? And how has bioinformatics help better identify carrier risk?

Can you take us through the flow of an actual patient and explain how you use SNP-based NGS carrier screening to provide genetic counseling?

Can you take us through the flow of an actual patient and explain how you use SNP-based NGS carrier screening to provide genetic counseling?

What types of diseases are typically considered for carrier screening?

What types of diseases are typically considered for carrier screening?

How does carrier screening differ from diagnostic testing?

How does carrier screening differ from diagnostic testing?

What are the recommended guidelines for carrier screening? What are the similarities and differences among different professional societies and associations?

What are the recommended guidelines for carrier screening? What are the similarities and differences among different professional societies and associations?

What are the recommended next steps for couples who screen positive?

What are the recommended next steps for couples who screen positive?

How has carrier screening for cystic fibrosis changed?

How has carrier screening for cystic fibrosis changed?

What are the benefits of enhanced SMA (spinal muscular atrophy) testing?

What are the benefits of enhanced SMA (spinal muscular atrophy) testing?

What are the benefits of AGG interruption testing as part of carrier screening for Fragile X syndrome?

What are the benefits of AGG interruption testing as part of carrier screening for Fragile X syndrome?

Why is carrier screening for Duchenne Muscular Dystrophy now being offered?

Why is carrier screening for Duchenne Muscular Dystrophy now being offered?

What is the benefit of molecular carrier screening for hemoglobinopathies when the gold standard for screening has been CBC with hemoglobin electrophoresis?

What is the benefit of molecular carrier screening for hemoglobinopathies when the gold standard for screening has been CBC with hemoglobin electrophoresis?


How long does it typically take to receive carrier screening results?

How long does it typically take to receive carrier screening results?

Are all expanded carrier screenings the same? How do these technologies differ? What screening technology do you use and why?

Are all expanded carrier screenings the same? How do these technologies differ? What screening technology do you use and why?

Is it appropriate to offer concurrent patient/partner carrier screening?

Is it appropriate to offer concurrent patient/partner carrier screening?

How often do we encounter false-positive and false-negative results and how do we determine positive predictive value?

How often do we encounter false-positive and false-negative results and how do we determine positive predictive value?

What impact do the results of carrier screening have on non-health related issues and affordability?

What impact do the results of carrier screening have on non-health related issues and affordability?